Median net sales for the 19 drugs in 2022 were $1.97 billion (range, $988 million-$8.36 billion). The drugs with the highest net sales were lenalidomide (Revlimid; $8.36 billion), ...

As the first human case of H5N5 bird flu is confirmed in the US, here are some frequently asked questions about the disease, ...

Of all the ways our immune system can run amok and damage the body instead of protecting it, autoimmune encephalitis is one ...

ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies - Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and ...

AI integration in cancer care aids patients in navigating complex treatment decisions and identifying relevant clinical ...

Rare diseases reveal that our sense of identity rests on fragile biological infrastructure, much of it operating outside ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for ...

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to ...

The National Institutes of Health awarded more than $8 million to the Kennedy Krieger Institute for researching rare ...

Maine faces a severe shortage of health care workers, with projected gaps in primary care doctors and many nearing retirement ...

Scientists at Brigham and Women's Hospital and Harvard Medical School have developed a targeted genetic test to improve ...